Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
A reduced capacity for mitochondrial fatty acid oxidation in skeletal muscle has been proposed as a major factor leading to the accumulation of intramuscular lipids and their subsequent deleterious effects on insulin action. Here, we examine markers of mitochondrial fatty acid oxidative capacity in rodent models of insulin resistance associated with an oversupply of lipids. C57BL/6J mice were fed a high-fat diet for either 5 or 20 weeks. Several markers of muscle mitochondrial fatty acid oxidative capacity were measured, including 14C-palmitate oxidation, palmitoyl-CoA oxidation in isolated mitochondria, oxidative enzyme activity (citrate synthase, β-hydroxyacyl CoA dehydrogenase, medium-chain acyl-CoA dehydrogenase, and carnitine palmitoyl-transferase 1), and expression of proteins involved in mitochondrial metabolism. Enzyme activity and mitochondrial protein expression were also examined in muscle from other rodent models of insulin resistance. Compared with standard diet–fed controls, muscle from fat-fed mice displayed elevated palmitate oxidation rate (5 weeks +23%, P < 0.05, and 20 weeks +29%, P < 0.05) and increased palmitoyl-CoA oxidation in isolated mitochondria (20 weeks +49%, P < 0.01). Furthermore, oxidative enzyme activity and protein expression of peroxisome proliferator–activated receptor γ coactivator (PGC)-1α, uncoupling protein (UCP) 3, and mitochondrial respiratory chain subunits were significantly elevated in fat-fed animals. A similar pattern was present in muscle of fat-fed rats, obese Zucker rats, and db/db mice, with increases observed for oxidative enzyme activity and expression of PGC-1α, UCP3, and subunits of the mitochondrial respiratory chain. These findings suggest that high lipid availability does not lead to intramuscular lipid accumulation and insulin resistance in rodents by decreasing muscle mitochondrial fatty acid oxidative capacity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Turner et al. (15) recently reported that a high-fat diet resulted in increases in mitochondrial biogenesis and fatty acid oxidative capacity in skeletal muscle of mice.”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [15]
In the citing paper
“Similar observations emerged from other laboratories that likewise reported increased oxidative capacity, β-oxidation enzyme activities and mitochondrial biogenesis in parallel with high fat feeding and the onset of both obesity and insulin resistance in rodents [26,30,51,85,96].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [85]
In the citing paper
“However, rodent studies have found that an increase in mitochondrial biogenesis occurs concomitantly with the development of muscle insulin resistance, implying that this notion is incorrect.209,210”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [210]
In the citing paper
“While reduced FA oxidation was observed in obese human muscle (39, 42), increased FA oxidation in muscle tissue was found in several HF-fed rodent models (19, 43).”
From Mitochondrial Fission Contributes to Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle (2012) · cites this paper as [43]
In the citing paper
“Insulin resistance is not always associated with reduced mitochondrial respiration, as reported in rodents on a high-fat diet (HFD) (86-89) or in humans (90).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [89]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“Consistent with the observed defects in mitochondrial metabolism in insulin resistance and type 2 diabetes, some (12,13), but not all (6,14), studies have shown reduced expression of peroxisome proliferator–activated receptor (PPAR) coactivator (PGC)-1 , a transcriptional coactivator that is a key regulator of mitocho…”
BackgroundDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 2×
“These results may be confounded by various disease factors; however, investigations demonstrating mitochondrial defects in first-degree relatives of patients with type 2 diabetes (6,11,12) suggest that mitochondrial dysfunction may be among the earliest defects that predisposes these subjects to lipid accumulation and…”
BackgroundResultMetabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 3×
“Consistent with the observed defects in mitochondrial metabolism in insulin resistance and type 2 diabetes, some (12,13), but not all (6,14), studies have shown reduced expression of peroxisome proliferator–activated receptor (PPAR) coactivator (PGC)-1 , a transcriptional coactivator that is a key regulator of mitocho…”
BackgroundMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“In vivo functional studies using magnetic resonance spectroscopy have also demonstrated reduced mitochondrial oxidative and phosphorylation capacities in skeletal muscle from insulin-resistant elderly subjects (9), From the (1)Diabetes and Obesity Program, Garvan Institute of Medical Research, Darlinghurst, Australia;…”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · cited 2×
“These results may be confounded by various disease factors; however, investigations demonstrating mitochondrial defects in first-degree relatives of patients with type 2 diabetes (6,11,12) suggest that mitochondrial dysfunction may be among the earliest defects that predisposes these subjects to lipid accumulation and…”
BackgroundResultPeroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Morino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811 · cited 2×
“These results may be confounded by various disease factors; however, investigations demonstrating mitochondrial defects in first-degree relatives of patients with type 2 diabetes (6,11,12) suggest that mitochondrial dysfunction may be among the earliest defects that predisposes these subjects to lipid accumulation and…”
BackgroundResultCytokine Stimulation of Energy Expenditure through p38 MAP Kinase Activation of PPARγ Coactivator-1
Puigserver, P., Rhee, J., Lin, J., Wu, Z., Yoon, J. C., Zhang, C.-Y., Krauss, S., Mootha, V. K., Lowell, B. B., & Spiegelman, B. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00390-2 · Cited by 732 · cited 1×
“Furthermore, it must also be noted that many studies in rodents and humans have only examined mRNA expression for PGC-1 , and as PGC-1 is known to be posttranslationally modified, its gene expression may not always correlate with protein levels (40).”
BackgroundMalonyl-CoA, fuel sensing, and insulin resistance
Ruderman, N. B., Saha, A. K., Vavvas, D., & Witters, L. A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.1.e1 · Cited by 650 · cited 1×
“Another factor to be considered is that our ex vivo measurements represent the capacity of enzymes and fatty acid oxidation pathways under favorable conditions of substrate availability, and in vivo, regulatory factors such as elevated levels of malonyl-CoA (43) or reduced activity of adiponectin and leptin signaling…”
BackgroundLipid oxidation is reduced in obese human skeletal muscle
Kim, J.-Y., Hickner, R. C., Cortright, R. L., Dohm, G. L., & Houmard, J. A. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1039 · Cited by 634
Sparks, L. M., Xie, H., Koza, R. A., Mynatt, R., Hulver, M. W., Bray, G. A., & Smith, S. R. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1926 · Cited by 629 · cited 1×
“Dietary studies in humans are also equivocal with high-fat feeding studies reporting increases (48), decreases (24), or no change (49) in various markers of muscle mitochondrial metabolism.”
ResultWang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E. (2006) · Endocrinology · doi:10.1210/en.2006-0251 · Cited by 600
The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity
Viollet, B., Andreelli, F., Jørgensen, S. B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16567 · Cited by 499 · cited 1×
“25 Ci/ml [(3)H]-2-DOG as described previously (25).”
Simoneau, J., Veerkamp, J. H., Turcotte, L. P., & Kelley, D. E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2051 · Cited by 491 · cited 1×
“In muscle from obese insulin-resistant humans, the activity of enzymes of oxidative metabolism and fatty acid utilization are reduced (5).”
BackgroundKoves, T. R., Li, P., An, J., Akimoto, T., Slentz, D., Ilkayeva, O., Dohm, G. L., Yan, Z., Newgard, C. B., & Muoio, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507621200 · Cited by 464 · cited 1×
“Recently, it has been suggested that a reduced ratio of complete (measured as CO2 production) to incomplete (measured as acid-soluble metabolites) fatty acid oxidation may be important in high-fat diet–induced insulin resistance (23); however, we observed no difference in this ratio between standard diet– and fat-fed…”
BackgroundBonen, A., Parolin, M. L., Steinberg, G. R., Calles‐Escandon, J., Tandon, N. N., Glatz, J. F. C., Luiken, J. J. F. P., Heigenhauser, G. J. F., & Dyck, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1065fje · Cited by 410
Schuler, M., Ali, F., Chambon, C., Duteil, D., Bornert, J.-M., Tardivel, A., Desvergne, B., Wahli, W., Chambon, P., & Metzger, D. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.003 · Cited by 367
Bruce, C. R., Thrush, A. B., Mertz, V. A., Bezaire, V., Chabowski, A., Heigenhauser, G. J. F., & Dyck, D. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00587.2005 · Cited by 328 · cited 2×
“Citrate synthase, HAD, and MCAD activities were determined directly in muscle homogenates, while CPT-1 activity was determined in isolated mitochondria and is expressed per gram wet weight based on recovery rates of citrate synthase (27).”
MethodSelf-citationSchrauwen-Hinderling, V. B., Kooi, M. E., Hesselink, M. K. C., Jeneson, J. A. L., Backes, W. H., van Echteld, C. J. A., van Engelshoven, J. M. A., Mensink, M., & Schrauwen, P. (2007) · Diabetologia · doi:10.1007/s00125-006-0475-1 · Cited by 304 · cited 1×
“from patients with type 2 diabetes (10), and from insulinresistant offspring of patients with type 2 diabetes (11).”
BackgroundRichardson, D. K., Kashyap, S., Bajaj, M., Cusi, K., Mandarino, S. J., Finlayson, J., DeFronzo, R. A., Jenkinson, C. P., & Mandarino, L. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408985200 · Cited by 259 · cited 1×
“Acute oversupply of lipids, via lipid infusion, has been shown to reduce gene expression for PGC-1 and mitochondrial respiratory chain components in muscle (45,46).”
BackgroundThe role of intramuscular lipid in insulin resistance
Hegarty, B. D., Furler, S. M., Ye, J., Cooney, G. J., & Kraegen, E. W. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01162.x · Cited by 256 · cited 5×
“Specifically, potent lipid metabolites, including fatty acyl CoAs, diacylglycerols, and ceramides, whose concentrations correlate with intramuscular triglyceride levels, have been shown to antagonize the metabolic actions of insulin in skeletal muscle (1).”
BackgroundSelf-citationCameron-Smith, D., Burke, L. M., Angus, D. J., Tunstall, R. J., Cox, G. R., Bonen, A., Hawley, J. A., & Hargreaves, M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.313 · Cited by 243 · cited 1×
“Dietary studies in humans are also equivocal with high-fat feeding studies reporting increases (48), decreases (24), or no change (49) in various markers of muscle mitochondrial metabolism.”
ResultLevak-Frank, S., Radner, H., Walsh, A., Stollberger, R., Knipping, G., Hoefler, G., Sattler, W., Weinstock, P. H., Breslow, J. L., & Zechner, R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118145 · Cited by 218 · cited 1×
“Mice with muscle-specific overexpression of lipoprotein lipase, which increases fatty acid influx into skeletal muscle, display extensive mitochondrial proliferation (32).”
BackgroundNawrocki, A., & Scherer, P. E. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.003 · Cited by 167 · cited 1×
“Another factor to be considered is that our ex vivo measurements represent the capacity of enzymes and fatty acid oxidation pathways under favorable conditions of substrate availability, and in vivo, regulatory factors such as elevated levels of malonyl-CoA (43) or reduced activity of adiponectin and leptin signaling…”
BackgroundHegarty, B. D., Cooney, G. J., Kraegen, E. W., & Furler, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1477 · Cited by 166 · cited 3×
“Excess lipid storage may be in part related to a greater increase in the efficiency of fatty acid uptake, as it has been observed in insulin-resistant rodents that there is increased clearance of fatty acid into muscle (3,4).”
BackgroundSelf-citationColl, T., Jové, M., Rodríguez‐Calvo, R., Eyre, E., Palomer, X., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez‐Carrera, M. (2006) · Diabetes · doi:10.2337/db05-1494 · Cited by 152
Adaptations to a high-fat diet that increase exercise endurance in male rats
Miller, W. C., Bryce, G. R., & Conlee, R. K. (1984) · Journal of Applied Physiology · doi:10.1152/jappl.1984.56.1.78 · Cited by 143
Uncoupling protein‐3: clues in an ongoing mitochondrial mystery
Bézaire, V., Seifert, E. L., & Harper, M. (2007) · The FASEB Journal · doi:10.1096/fj.06-6966rev · Cited by 139 · cited 2×
“We did not directly measure fatty acid uptake in our animals; however, adipose mass and circulating nonesterified fatty acids levels were elevated in fat-fed mice (Table 1), and the increased UCP3 protein in all of our rodent models is consistent with an increased influx of fatty acid into muscle (30,31,41).”
BackgroundEffects of Dietary Fat on Muscle Substrates, Metabolism, and Performance in Athletes
VOGT, M., PUNTSCHART, A., HOWALD, H., MUELLER, B., MANNHART, C., GFELLER-TUESCHER, L., MULLIS, P., & HOPPELER, H. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000069336.30649.bd · Cited by 120 · cited 1×
“Dietary studies in humans are also equivocal with high-fat feeding studies reporting increases (48), decreases (24), or no change (49) in various markers of muscle mitochondrial metabolism.”
ResultSchrauwen, P., Hoeks, J., & Hesselink, M. K. C. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.001 · Cited by 111 · cited 2×
“We did not directly measure fatty acid uptake in our animals; however, adipose mass and circulating nonesterified fatty acids levels were elevated in fat-fed mice (Table 1), and the increased UCP3 protein in all of our rodent models is consistent with an increased influx of fatty acid into muscle (30,31,41).”
BackgroundSkeletal muscle oxidative capacity in rats fed high-fat diet
Iossa, S., Mollica, M. P., Lionetti, L., Crescenzo, R., Botta, M., & Liverini, G. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801844 · Cited by 104
Turcotte, L. P., Swenberger, J. R., Zavitz Tucker, M., & Yee, A. J. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1389 · Cited by 100 · cited 2×
“Excess lipid storage may be in part related to a greater increase in the efficiency of fatty acid uptake, as it has been observed in insulin-resistant rodents that there is increased clearance of fatty acid into muscle (3,4).”
BackgroundKarlsson, H., Ahlsén, M., Zierath, J. R., Wallberg‐Henriksson, H., & Koistinen, H. A. (2006) · Diabetes · doi:10.2337/db05-0853 · Cited by 91 · cited 1×
“Consistent with the observed defects in mitochondrial metabolism in insulin resistance and type 2 diabetes, some (12,13), but not all (6,14), studies have shown reduced expression of peroxisome proliferator–activated receptor (PPAR) coactivator (PGC)-1 , a transcriptional coactivator that is a key regulator of mitocho…”
BackgroundFex, M., Nitert, M. D., Wierup, N., Sundler, F., Ling, C., & Mulder, H. (2006) · Diabetologia · doi:10.1007/s00125-006-0464-4 · Cited by 78 · cited 1×
“Fatty acids have also been shown to increase PGC-1 expression in muscle cells (33) and -cells (34), and this is associated with increased mitochondrial metabolism (33,35).”
BackgroundHoeks, J., Hesselink, M. K. C., Russell, A. P., Mensink, M., Saris, W. H. M., Mensink, R. P., & Schrauwen, P. (2006) · Diabetologia · doi:10.1007/s00125-006-0369-2 · Cited by 74 · cited 1×
“Acute oversupply of lipids, via lipid infusion, has been shown to reduce gene expression for PGC-1 and mitochondrial respiratory chain components in muscle (45,46).”
BackgroundJové, M., Salla, J., Planavila, A., Cabrero, À., Michalik, L., Wahli, W., Laguna, J. C., & Vázquez‐Carrera, M. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300208-jlr200 · Cited by 72
Molero, J. C., Waring, S. G., Cooper, A., Turner, N. A., Laybutt, D. R., Cooney, G. J., & James, D. E. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0312 · Cited by 48 · cited 1×
“Citrate synthase, -hydroxyacyl CoA dehydrogenase ( HAD), and medium-chain acyl-CoA dehydrogenase (MCAD) were determined at 30°C, as described previously (28,29), using a Spectra Max 250 microplate spectrophotometer (Molecular Devices, Sunnyvale, CA).”
MethodSelf-citationStaiger, H., Staiger, K., Haas, C., Weisser, M., Machicao, F. E., & Häring, H.-U. (2005) · Diabetologia · doi:10.1007/s00125-005-1895-z · Cited by 47
Free fatty acids increase PGC‐1α expression in isolated rat islets
Zhang, P., Liu, C., Zhang, C., Zhang, Y., Shen, P., Zhang, J., & Zhang, C.-Y. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.046 · Cited by 45
Interaction of Diet and Training on Endurance Performance in Rats
Lee, J. S., Bruce, C. R., Spriet, L. L., & Hawley, J. A. (2001) · Experimental Physiology · doi:10.1113/eph8602158 · Cited by 44
Self-citationMuscle morphological and biochemical adaptations to training in obese Zucker rats
Torgan, C. E., Brozinick, J. T., Kastello, G. M., & Ivy, J. L. (1989) · Journal of Applied Physiology · doi:10.1152/jappl.1989.67.5.1807 · Cited by 43
Bajaj, M., Medina-Navarro, R., Suraamornkul, S., Meyer, C., DeFronzo, R. A., & Mandarino, L. J. (2007) · Diabetes · doi:10.2337/db06-0840 · Cited by 38 · cited 1×
“However, 1 week of pharmacological reduction of plasma free fatty acids (and subsequently intramuscular acyl-CoA concentrations) in insulin-resistant subjects also reduced gene expression of PGC-1 and other mitochondrial markers in muscle (47).”
BackgroundBenton, C. R., Han, X.-X., Febbraio, M., Graham, T. E., & Bonen, A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00781.2005 · Cited by 33
Djouadi, F., Riveau, B., Merlet-Bénichou, C., & Bastin, J. (1997) · Biochemical Journal · doi:10.1042/bj3240289 · Cited by 31 · cited 1×
“Citrate synthase, -hydroxyacyl CoA dehydrogenase ( HAD), and medium-chain acyl-CoA dehydrogenase (MCAD) were determined at 30°C, as described previously (28,29), using a Spectra Max 250 microplate spectrophotometer (Molecular Devices, Sunnyvale, CA).”
MethodKratky, D., Bogner‐Strauß, J. G., & Zechner, R. (2001) · Biochemical Journal · doi:10.1042/bj3550647 · Cited by 31 · cited 1×
“We did not directly measure fatty acid uptake in our animals; however, adipose mass and circulating nonesterified fatty acids levels were elevated in fat-fed mice (Table 1), and the increased UCP3 protein in all of our rodent models is consistent with an increased influx of fatty acid into muscle (30,31,41).”
BackgroundPlanavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez‐Carrera, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.08.001 · Cited by 26 · cited 1×
“The fatty acid subtype appears to be important (33), as palmitate alone reduces PGC-1 expression (36); however, this may be related to its activation of inflammatory pathways that are known to impact on PGC-1 expression (37).”
BackgroundFiber type composition and enzyme activities of muscles in two models of obese rats
Pujol, A., Lefaucheur, L., Ecolan, P., Picon, L., & Pénicaud, L. (1993) · Comparative Biochemistry and Physiology Part B Comparative Biochemistry · doi:10.1016/0305-0491(93)90299-k · Cited by 14
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Sebastián, D., Hernández-Alvarez, M. I., Segalés, J., Sorianello, E., Muñoz, J. P., Sala, D., Waget, A., Liesa, M., Paz, J. C., Gopalacharyulu, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108220109 · Cited by 673
Jheng, H.-F., Tsai, P.-J., Guo, S.-M., Kuo, L.-H., Chang, C.-S., Su, I.-J., Chang, C.-R., & Tsai, Y.-S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05603-11 · Cited by 650
“While reduced FA oxidation was observed in obese human muscle (39, 42), increased FA oxidation in muscle tissue was found in several HF-fed rodent models (19, 43).”
Background
Metadata
- Authors
- Turner, N., Bruce, C. R., Beale, S. M., Hoehn, K. L., So, T., Rolph, M. S., & Cooney, G. J.
- Affiliations
- Garvan Institute of Medical Research (AU)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-08-01
- Volume
- 56
- Issue
- 8
- Pages
- 2085-2092
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2088262190
- Cited by
- 520
- References
- 49
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 6 · 2023: 16 · 2022: 21 · 2021: 22 · 2020: 31 · 2019: 24 · 2018: 33 · 2017: 28 · 2016: 25 · 2015: 31 · 2014: 38 · 2013: 37 · 2012: 43
- FWCI
- 25.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Diabetes Australia Research Trust
- Diabetes Australia
- Rebecca L. Cooper Medical Research Foundation
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- mitochondrial fatty acid oxidation, skeletal muscle, insulin resistance, high-fat diet, palmitate oxidation, palmitoyl-CoA oxidation, PGC-1α, UCP3, mitochondrial respiratory chain, carnitine palmitoyltransferase 1, beta-hydroxyacyl-CoA dehydrogenase, citrate synthase, Zucker fatty rats, db/db mice, lipid availability
- MeSH terms
- Animals, Fats, Fatty Acids, Glucose, Glucose Tolerance Test, Insulin Resistance, Male, Mitochondria, Muscles, Obesity, Oxidation-Reduction, Oxygen, Biomarkers, Mitochondrial Proteins, Lipid Metabolism, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.